XPACE-1008
Pipeline Category
Pharmaceutical
Short Description / Indication
AI Overview
XPACE-1008 is an IL-2 modulator drug initially developed by the biotechnology company Xanadu Bio Inc.
Licensees
| Company Name | Company Website URL |
|---|---|
| Xanadu Bio | https://xanadubio.com/ |
Pharmaceutical Status